Edwards Lifesciences CorporationEWNYSE
LOADING
|||
Net Income Scaling
Trending higher, above historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$4.17B
↑ 224% above average
Average (9y)
$1.29B
Historical baseline
Range
High:$4.17B
Low:$494.90M
CAGR
+26.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $4.17B | +197.7% |
| 2023 | $1.40B | -7.9% |
| 2022 | $1.52B | +1.3% |
| 2021 | $1.50B | +82.5% |
| 2020 | $823.40M | -21.3% |
| 2019 | $1.05B | +45.0% |
| 2018 | $722.20M | +16.1% |
| 2017 | $622.10M | +9.2% |
| 2016 | $569.50M | +15.1% |
| 2015 | $494.90M | - |